The Clinical Trials on Alzheimer’s Disease (CTAD) conference is an annual event focused on clinical research in Alzheimer’s disease. Established in 2008, it provides a platform for AD researchers to discuss clinical trials, biomarkers, therapies, and related advancements through presentations, posters, and discussions.
The 18th edition (CTAD 2025) took place in San Diego, California, from December 1 to 4, 2025. It featured sessions on topics such as digital health, e-trials, biomarkers, and novel therapeutics, with contributions from companies like Merck presenting data on Alzheimer’s candidates.
